314 related articles for article (PubMed ID: 12096000)
21. A p-[18F]fluoroethoxyphenyl bicyclic nucleoside analogue as a potential positron emission tomography imaging agent for varicella-zoster virus thymidine kinase gene expression.
Chitneni SK; Deroose CM; Balzarini J; Gijsbers R; Celen S; Debyser Z; Mortelmans L; Verbruggen AM; Bormans GM
J Med Chem; 2007 Dec; 50(26):6627-37. PubMed ID: 18047266
[TBL] [Abstract][Full Text] [Related]
22. Selective abolishment of pyrimidine nucleoside kinase activity of herpes simplex virus type 1 thymidine kinase by mutation of alanine-167 to tyrosine.
Degrève B; Esnouf R; De Clercq E; Balzarini J
Mol Pharmacol; 2000 Dec; 58(6):1326-32. PubMed ID: 11093770
[TBL] [Abstract][Full Text] [Related]
23. Comparative cytostatic activity of different antiherpetic drugs against herpes simplex virus thymidine kinase gene-transfected tumor cells.
Balzarini J; Bohman C; Walker RT; de Clercq E
Mol Pharmacol; 1994 Jun; 45(6):1253-8. PubMed ID: 8022417
[TBL] [Abstract][Full Text] [Related]
24. Testing the sensitivities of noncognate inhibitors to varicella zoster virus thymidine kinase: implications for postherpetic neuralgia therapy with existing agents.
Yang L; Mo X; Yang H; Dai H; Tan F
J Mol Model; 2014 Jul; 20(7):2321. PubMed ID: 24961898
[TBL] [Abstract][Full Text] [Related]
25. Synthesis and antiviral properties of 5-vinylpyrimidine nucleoside analogs.
De Clercq E; Walker RT
Pharmacol Ther; 1984; 26(1):1-44. PubMed ID: 6099893
[TBL] [Abstract][Full Text] [Related]
26. Discovery and development of BVDU (brivudin) as a therapeutic for the treatment of herpes zoster.
De Clercq E
Biochem Pharmacol; 2004 Dec; 68(12):2301-15. PubMed ID: 15548377
[TBL] [Abstract][Full Text] [Related]
27. Anti-herpesvirus activities and cytotoxicities of 2-thiopyrimidine nucleoside analogues in vitro.
Shigeta S; Mori S; Kira T; Takahashi K; Kodama E; Konno K; Nagata T; Kato H; Wakayama T; Koike N; Saneyoshi M
Antivir Chem Chemother; 1999 Jul; 10(4):195-209. PubMed ID: 10480738
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and antiviral evaluation of some 3'-fluoro bicyclic nucleoside analogues.
McGuigan C; Carangio A; Snoeck R; Andrei G; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):1-5. PubMed ID: 15043132
[TBL] [Abstract][Full Text] [Related]
29. ASP2151, a novel helicase-primase inhibitor, possesses antiviral activity against varicella-zoster virus and herpes simplex virus types 1 and 2.
Chono K; Katsumata K; Kontani T; Kobayashi M; Sudo K; Yokota T; Konno K; Shimizu Y; Suzuki H
J Antimicrob Chemother; 2010 Aug; 65(8):1733-41. PubMed ID: 20534624
[TBL] [Abstract][Full Text] [Related]
30. Phosphonoamidate prodrugs of C5-substituted pyrimidine acyclic nucleosides for antiviral therapy.
Pertusati F; Serafini S; Albadry N; Snoeck R; Andrei G
Antiviral Res; 2017 Jul; 143():262-268. PubMed ID: 28454912
[TBL] [Abstract][Full Text] [Related]
31. Synergistic inhibition of herpesvirus replication by docosanol and antiviral nucleoside analogs.
Marcelletti JF
Antiviral Res; 2002 Nov; 56(2):153-66. PubMed ID: 12367721
[TBL] [Abstract][Full Text] [Related]
32. Mutation of Gln125 to Asn selectively abolishes the thymidylate kinase activity of herpes simplex virus type 1 thymidine kinase.
Degrève B; Esnouf R; De Clercq E; Balzarini J
Mol Pharmacol; 2001 Feb; 59(2):285-93. PubMed ID: 11160865
[TBL] [Abstract][Full Text] [Related]
33. 5-(1-Substituted) alkyl pyrimidine nucleosides as antiviral (herpes) agents.
Kumar R
Curr Med Chem; 2004 Oct; 11(20):2749-66. PubMed ID: 15544474
[TBL] [Abstract][Full Text] [Related]
34. β-l-1-[5-(E-2-bromovinyl)-2-(hydroxymethyl)-1,3-(dioxolan-4-yl)] uracil (l-BHDU) prevents varicella-zoster virus replication in a SCID-Hu mouse model and does not interfere with 5-fluorouracil catabolism.
De C; Liu D; Zheng B; Singh US; Chavre S; White C; Arnold RD; Hagen FK; Chu CK; Moffat JF
Antiviral Res; 2014 Oct; 110():10-9. PubMed ID: 25051026
[TBL] [Abstract][Full Text] [Related]
35. Bicyclic furo pyrimidine nucleosides with aryloxyphenyl and halophenyl substituted side chains as potent and selective varicella-zoster virus inhibitors.
Blewett S; McGuigan C; Barucki H; Andrei G; Snoeck R; De Clercq E; Balzarini J
Nucleosides Nucleotides Nucleic Acids; 2001; 20(4-7):1063-6. PubMed ID: 11562959
[TBL] [Abstract][Full Text] [Related]
36. FV-100 for the Treatment of Varicella-Virus (VZV) Infections: Quo Vadis?
De Clercq E
Viruses; 2022 Apr; 14(4):. PubMed ID: 35458500
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of novel phosphoramidate ProTides of the 2'-fluoro derivatives of a potent anti-varicella zoster virus bicyclic nucleoside analogue.
Derudas M; Quintiliani M; Brancale A; Andrei G; Snoeck R; Balzarini J; McGuigan C
Antivir Chem Chemother; 2010 Oct; 21(1):15-31. PubMed ID: 21045257
[TBL] [Abstract][Full Text] [Related]
38. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines.
Migliore MD; Zonta N; McGuigan C; Henson G; Andrei G; Snoeck R; Balzarini J
J Med Chem; 2007 Dec; 50(26):6485-92. PubMed ID: 18052321
[TBL] [Abstract][Full Text] [Related]
39. Bicyclic nucleoside inhibitors of Varicella-Zoster virus: the effect of branching in the p-alkylphenyl side chain.
Luoni G; McGuigan C; Andrei G; Snoeck R; De Clercq E; Balzarini J
Bioorg Med Chem Lett; 2005 Aug; 15(16):3791-6. PubMed ID: 15993062
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological evaluation of 5-substituted derivatives of the potent antiherpes agent (north)-methanocarbathymine.
Russ P; Schelling P; Scapozza L; Folkers G; Clercq ED; Marquez VE
J Med Chem; 2003 Nov; 46(23):5045-54. PubMed ID: 14584954
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
